Public issue by IRFC of the tax free, secured, redeemable, non-convertible bonds of face value of Rs.1,000 each in the nature of debentures having tax benefits under section 10(15)(iv)(h) of the IT Act 1961, as amended, aggregating upto Rs.3,505.5 Cr in the FY 2013.The Bonds will be issued in one or more tranches subject to Shelf Limit. This Tranche Issue of bonds aggregates to Rs.1000 Cr with an...
Public Issue by Rural Electrification Corporation Limited (REC or Issuer or the Company) of Tax Free Secured Redeemable Non Convertible Bonds of Face Value of Rs.1,000 each in the nature of debentures having tax benefits under Section 10 (15)(iv)(h) of the Income Tax Act, 1961, as amended (Bonds) for an amount aggregating upto the Shelf Limit* (Rs.4,500 crores) by way of issuance of Bonds in one or more tranches in the Fiscal 2013 (each a Tranche Issue, and together all Tranche Issues upto the Shelf Limit,Issue).This Tranche Issue by the Issuer is of Bonds aggregating to Rs.100 Cr with an option to...
Note: 1)*In the event of such early closure of the subscription list of the Issue, HUDCO shall ensure that public notice of such early closure is published on or before the day of such early date of closure through advertisement/s in a leading national daily newspaper. 2)** Not more than 10% of the shelf Limit will be allocated to investors who are FIIs (Category I), eligible NRIs (Categories III & IV) and all other non resident...
Public issue of the tax free bonds in the nature of secured redeemable non-convertible bonds of the Company of face value of Rs.1,000 each, having benefits under section 10(15)(iv)(h) of the IT Act 1961, proposed to be issued by the Company pursuant to the relevant Tranche Prospectus, for an amount up to Rs.5,000 Cr .THE CBDT has,by the CBDT notification, authorized our company to raise the bonds aggregating to Rs.5,000 Cr in FY13.The Company proposes to raise Rs.750Cr through the issue with an...
Public issue of the tax free bonds in the nature of secured redeemable non-convertible bonds of the Company of face value of Rs.1,000 each, having benefits under section 10(15)(iv)(h) of the IT Act 1961, as amended, aggregating upto Rs.8,88,640 Lakhs in the FY 2013.The Bonds will be issued in one or...
and developing markets of the world. It has grown to become the 14 largest generic pharmaceutical company in the world with a CAGR of 26% in Gross Sales, 30% in EBITDA and 31% in Net Profits for the last 7 years. It operates 10 world class manufacturing facilities...
